Designing Protein Binders Using the Generative Model Proteina-Complexa

Developing new protein-based therapies and catalysts involves the challenging task of designing protein binders, or proteins that bind to a target protein or small molecule, according to NVIDIA BioNeMo.

Researchers at NVIDIA have developed a generative model called Proteina-Complexa to design protein binders.

The model uses a combination of machine learning algorithms to predict the binding affinity of a protein to a target protein or small molecule.

This approach can potentially accelerate the development of new protein-based therapies and catalysts.